Rapid development of hyponatraemia during low-dose carbamazepine therapy.
D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy*
D002220:Carbamazepine